Karen Martins

2.7k total citations
22 papers, 589 citations indexed

About

Karen Martins is a scholar working on Infectious Diseases, Epidemiology and Emergency Medical Services. According to data from OpenAlex, Karen Martins has authored 22 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 8 papers in Epidemiology and 5 papers in Emergency Medical Services. Recurrent topics in Karen Martins's work include Viral Infections and Outbreaks Research (17 papers), Viral Infections and Vectors (10 papers) and Viral gastroenteritis research and epidemiology (8 papers). Karen Martins is often cited by papers focused on Viral Infections and Outbreaks Research (17 papers), Viral Infections and Vectors (10 papers) and Viral gastroenteritis research and epidemiology (8 papers). Karen Martins collaborates with scholars based in United States, Colombia and Democratic Republic of the Congo. Karen Martins's co-authors include Sina Bavari, Andres Μ. Salazar, Jesse Steffens, Christopher L. Cooper, Sean A. Van Tongeren, Travis K. Warren, Peter B. Jahrling, Jens H. Kuhn, Aileen Y. Chang and Nelly Pacheco and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Karen Martins

21 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Martins United States 14 344 185 147 139 98 22 589
Viki Bockstal Netherlands 14 283 0.8× 151 0.8× 239 1.6× 134 1.0× 51 0.5× 25 525
W Kell United States 9 454 1.3× 148 0.8× 157 1.1× 115 0.8× 52 0.5× 9 664
Michelle Meyer United States 14 455 1.3× 92 0.5× 140 1.0× 222 1.6× 186 1.9× 21 726
Ravi Prakash Arya India 10 274 0.8× 143 0.8× 165 1.1× 238 1.7× 76 0.8× 16 534
Colette Pietzsch United States 14 404 1.2× 116 0.6× 151 1.0× 52 0.4× 179 1.8× 22 616
Hugues Fausther‐Bovendo Canada 14 349 1.0× 287 1.6× 176 1.2× 36 0.3× 150 1.5× 32 757
Kristin M. Long United States 12 319 0.9× 115 0.6× 99 0.7× 283 2.0× 102 1.0× 17 565
Erika Garner‐Spitzer Austria 14 211 0.6× 269 1.5× 146 1.0× 61 0.4× 128 1.3× 30 639
André M. Vale Brazil 17 197 0.6× 319 1.7× 356 2.4× 430 3.1× 125 1.3× 45 890
Manisha Gupta United States 12 635 1.8× 98 0.5× 235 1.6× 53 0.4× 43 0.4× 12 738

Countries citing papers authored by Karen Martins

Since Specialization
Citations

This map shows the geographic impact of Karen Martins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Martins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Martins more than expected).

Fields of papers citing papers by Karen Martins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Martins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Martins. The network helps show where Karen Martins may publish in the future.

Co-authorship network of co-authors of Karen Martins

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Martins. A scholar is included among the top collaborators of Karen Martins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Martins. Karen Martins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hofmeyer, Kimberly A., Christy L. Ventura, Kimberly L. Armstrong, et al.. (2024). Project NextGen: Developing the Next Generation of COVID-19 Vaccines and Therapeutics to Respond to the Present and Prepare for the Future. Clinical Infectious Diseases. 79(1). 115–121. 6 indexed citations
2.
Martins, Karen & Daniel Wolfe. (2024). Marburg Virus Medical Countermeasures. Methods in molecular biology. 2877. 25–43.
3.
Sprecher, Armand, Robert W. Cross, Andrea Marzi, et al.. (2023). Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector Meeting. The Journal of Infectious Diseases. 228(Supplement_7). S474–S478. 3 indexed citations
4.
Crozier, Ian, Kyla A. Britson, Daniel Wolfe, et al.. (2022). The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next Steps. Vaccines. 10(8). 1213–1213. 13 indexed citations
5.
Cooper, Christopher L., et al.. (2020). Adjuvant selection impacts the correlates of vaccine protection against Ebola infection. Vaccine. 38(29). 4601–4608. 10 indexed citations
6.
Martins, Karen, et al.. (2019). Glucopyranosyl lipid adjuvant enhances immune response to Ebola virus-like particle vaccine in mice. Vaccine. 37(29). 3902–3910. 17 indexed citations
7.
Martins, Karen, Melissa K. Gregory, Thomas R. Sprague, et al.. (2019). Neutralizing Antibodies from Convalescent Chikungunya Virus Patients Can Cross-Neutralize Mayaro and Una Viruses. American Journal of Tropical Medicine and Hygiene. 100(6). 1541–1544. 30 indexed citations
8.
Chang, Aileen Y., Sarah R. Tritsch, St Patrick Reid, et al.. (2018). The Cytokine Profile in Acute Chikungunya Infection is Predictive of Chronic Arthritis 20 Months Post Infection. SHILAP Revista de lepidopterología. 6(4). 95–95. 19 indexed citations
9.
Cooper, Christopher L., et al.. (2017). T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection. Emerging Microbes & Infections. 6(1). 1–9. 13 indexed citations
10.
Keshtkar‐Jahromi, Maryam, Karen Martins, Anthony P. Cardile, et al.. (2017). Treatment-focused Ebola trials, supportive care and future of filovirus care. Expert Review of Anti-infective Therapy. 16(1). 67–76. 7 indexed citations
11.
Martins, Karen, John M. Dye, & Sina Bavari. (2016). Considerations for the development of Zika virus vaccines. Vaccine. 34(33). 3711–3712. 8 indexed citations
12.
Martins, Karen, Peter B. Jahrling, Sina Bavari, & Jens H. Kuhn. (2016). Ebola virus disease candidate vaccines under evaluation in clinical trials. Expert Review of Vaccines. 15(9). 1101–1112. 37 indexed citations
13.
Cazares, Lisa H., Michael D. Ward, Ernst E. Brueggemann, et al.. (2016). Development of a liquid chromatography high resolution mass spectrometry method for the quantitation of viral envelope glycoprotein in Ebola virus-like particle vaccine preparations. Clinical Proteomics. 13(1). 18–18. 11 indexed citations
14.
Martins, Karen, Christopher L. Cooper, Sarah L. Norris, et al.. (2015). Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity. EBioMedicine. 3. 67–78. 48 indexed citations
15.
Carra, John H., et al.. (2015). A thermostable, chromatographically purified Ebola nano-VLP vaccine. Journal of Translational Medicine. 13(1). 228–228. 14 indexed citations
16.
Martins, Karen, John H. Carra, Christopher L. Cooper, et al.. (2014). Cross-Protection Conferred by Filovirus Virus-Like Particles Containing Trimeric Hybrid Glycoprotein. Viral Immunology. 28(1). 62–70. 18 indexed citations
17.
Martins, Karen, Christopher L. Cooper, Travis K. Warren, et al.. (2014). Characterization of Clinical and Immunological Parameters During Ebola Virus Infection of Rhesus Macaques. Viral Immunology. 28(1). 32–41. 27 indexed citations
18.
Martins, Karen, Sina Bavari, & Andres Μ. Salazar. (2014). Vaccine adjuvant uses of poly-IC and derivatives. Expert Review of Vaccines. 14(3). 447–459. 167 indexed citations
19.
Martins, Karen, Jesse Steffens, Sean A. Van Tongeren, et al.. (2014). Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation. PLoS ONE. 9(2). e89735–e89735. 43 indexed citations
20.
Martins, Karen, Travis K. Warren, & Sina Bavari. (2013). Characterization of a putative filovirus vaccine: Virus-like particles. Virologica Sinica. 28(2). 65–70. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Viki Bockstal Breakdown of academic impact, for papers by W Kell Breakdown of academic impact, for papers by Michelle Meyer Breakdown of academic impact, for papers by Ravi Prakash Arya Breakdown of academic impact, for papers by Colette Pietzsch Breakdown of academic impact, for papers by Hugues Fausther‐Bovendo Breakdown of academic impact, for papers by Kristin M. Long Breakdown of academic impact, for papers by Erika Garner‐Spitzer Breakdown of academic impact, for papers by André M. Vale Breakdown of academic impact, for papers by Manisha Gupta
Rankless by CCL
2026